Fujifilm Biotech Breaks Ground on $1.6-Bn Expansion of Cell-Culture Mfg
By

By
Fujifilm Diosynth Biotechnologies, a contract biologics manufacturer, has broken ground on an expansion of its site in Hillerød, Denmark, to expand cell-culture biomanufacturing. The expansion is part of a $1.6-billion…

Biogen Sells Lab/Life-Sciences Property for $592 M
By

By
Biogen has completed the sale of its 271,000-square-foot laboratory/life sciences property in Cambridge, Massachusetts, to BXP, a commercial real estate developer and property management company, for $592 million. Following the…

Supplier News: Olon, Roquette, Evotec & More
By

By
The latest from CDMOs, CMOs, and suppliers featuring Olon, Roquette, Evotec, Archimica, and Cellistic. Chemicals/Chemical API Manufacturing* Olon Adding High-Containment Production Line* Archimica Starts Operations of $2-M API ExpansionBiologics Mfg*…

Mfg News: Roche, AbbVie, Civica Rx & MeiraGTx
By

By
A roundup of manufacturing news from Roche, AbbVie, Civica Rx, and MeiraGTx. Highlights below. * Roche’s Genentech Opens New $250-M Clinical Supply Center* AbbVie Investing $60 M to Expand Sterile…

Global Briefs: Novartis, Gilead, J&J, GSK & More
By

By
A roundup of news from Novartis, Gilead Sciences, MiroBio, bluebird bio, Johnson & Johnson, GlaxoSmithKline, Takeda, Pfizer, and CytoReason. Highlights below. * Novartis To Petition US Supreme Court To Hear…

COVID News: Pfizer, AstraZeneca, Gilead Sciences & More
By

By
The latest on COVID-19 vaccines/drugs and manufacturing from Pfizer, BioNTech, AstraZeneca, Gilead Sciences, IDT Biologika, Valneva, and Clover Biopharmaceuticals. Highlights below. Manufacturing and supply of COVID-19 vaccines and drugs* IDT…

President Biden Issues Executive Order To Advance Biomanufacturing, Biotech
By

By
President Joe Biden has issued an executive order to launch the National Biotechnology and Biomanufacturing Initiative to set forth the Administration’s goals to advance biotechnology and biomanufacturing. The White House…

HHS Outlines Actions for New National Biotechnology and Biomanufacturing Initiative
By

By
The US Department of Health and Human Services (HHS) has announced actions the department will take following the issuance an executive order by President Joe Biden to launch the National…

Novartis Investing $300 M for Early-Stage Biologics Technical Development
By

By
Novartis has announced a multi-year $300-million investment to bolster its capacity and capabilities for early technical development of biologics for both drug substances and drug products across existing Novartis sites…

Supplier News: Siegfried, Lonza, WuXi STA, BD & More
By

By
The latest from CDMOs, CMOs, and suppliers featuring Siegfried, Lonza, WuXi STA, F.I.S., Pace Life Sciences, Bora Pharmaceuticals, and BD. Chemicals/Chemical API Manufacturing* Siegfried Breaks Ground on $104-M Drug-Substance Mfg…